These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2541593)
1. Suppression of experimental autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition. Prosiegel M; Neu I; Mallinger J; Wildfeuer A; Mehlber L; Vogl S; Hoffmann G; Ruhenstroth-Bauer G Acta Neurol Scand; 1989 Mar; 79(3):223-6. PubMed ID: 2541593 [TBL] [Abstract][Full Text] [Related]
2. Release of PAF-acether and eicosanoids from guinea-pig alveolar macrophages by FMLP: effect of cyclo-oxygenase and lipoxygenase inhibition. Fitzgerald MF; Parente L; Whittle BJ Eur J Pharmacol; 1989 May; 164(3):539-46. PubMed ID: 2548873 [TBL] [Abstract][Full Text] [Related]
3. Suppression of active but not passive autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition. Simmons RD; Hugh AR; Willenborg DO; Cowden WB Acta Neurol Scand; 1992 Mar; 85(3):197-9. PubMed ID: 1575003 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of leukotriene-induced contraction of guinea pig trachea by 5-lipoxygenase inhibitors. Schwalm SF; Lewis AJ; Hand JM Prostaglandins; 1987 Jan; 33(1):113-9. PubMed ID: 3108959 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C. 1980. Randall RW; Eakins KE; Higgs GA; Salmon JA; Tateson JE Agents Actions; 1994 Dec; 43(3-4):176-8; discussion 167. PubMed ID: 7725969 [No Abstract] [Full Text] [Related]
6. Arachidonic acid-induced pleurisy (ARIP): an in vivo model for testing 5-lipoxygenase inhibition. Boctor AM; Burke C; Hovinga ME Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):793-7. PubMed ID: 2831442 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukotriene C4 and B4 generation by human eosinophils and neutrophils with the lipoxygenase pathway inhibitors U60257 and BW755C. Cromwell O; Shaw RJ; Walsh GM; Mallet AI; Kay AB Int J Immunopharmacol; 1985; 7(5):775-81. PubMed ID: 2995265 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C. Randall RW; Eakins KE; Higgs GA; Salmon JA; Tateson JE Agents Actions; 1980 Dec; 10(6):553-5. PubMed ID: 6791482 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of leukotriene release in anaphylactic guinea-pig hearts by a 5-lipoxygenase inhibitor, CGS 8515. Yaacob HB; Piper PJ Br J Pharmacol; 1988 Dec; 95(4):1322-8. PubMed ID: 3146401 [TBL] [Abstract][Full Text] [Related]
12. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification]. Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577 [TBL] [Abstract][Full Text] [Related]
13. Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo. Beetens JR; Loots W; Somers Y; Coene MC; De Clerck F Biochem Pharmacol; 1986 Mar; 35(6):883-91. PubMed ID: 3006695 [TBL] [Abstract][Full Text] [Related]
14. Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro. Boctor AM; Eickholt M; Pugsley TA Prostaglandins Leukot Med; 1986 Aug; 23(2-3):229-38. PubMed ID: 3020588 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies into cyclo-oxygenase, lipoxygenase and phospholipase in smooth muscle contraction in the isolated trachea. Mitchell HW Br J Pharmacol; 1984 Jul; 82(3):549-55. PubMed ID: 6430374 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenase. Salmon JA; Tilling LC; Moncada S Prostaglandins; 1985 Mar; 29(3):377-85. PubMed ID: 2988019 [TBL] [Abstract][Full Text] [Related]
17. Failure of the inhibition of rat gastric mucosal 5-lipoxygenase by novel acetohydroxamic acids to prevent ethanol-induced damage. Boughton-Smith NK; Whittle BJ Br J Pharmacol; 1988 Sep; 95(1):155-62. PubMed ID: 3146394 [TBL] [Abstract][Full Text] [Related]
18. Suppression of experimental autoimmune encephalomyelitis by sulfasalazine. Prosiegel M; Neu I; Vogl S; Hoffmann G; Wildfeuer A; Ruhenstroth-Bauer G Acta Neurol Scand; 1990 Mar; 81(3):237-8. PubMed ID: 1972308 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of tissue damage by the arachidonate lipoxygenase inhibitor BW755C. Higgs GA; Mugridge KG; Moncada S; Vane JR Proc Natl Acad Sci U S A; 1984 May; 81(9):2890-2. PubMed ID: 6326150 [TBL] [Abstract][Full Text] [Related]
20. Simple procedure for measuring the pharmacodynamics and analgesic potential of lipoxygenase inhibitors. Carey F; Haworth D; Edmonds AE; Forder RA J Pharmacol Methods; 1988 Dec; 20(4):347-56. PubMed ID: 3145369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]